scholarly journals Neurotropic B vitamins: analgesic and anti-inflammatory effects

2020 ◽  
Vol 1 (2) ◽  
pp. 40-44
Author(s):  
Anton A. Beliaev ◽  
◽  
Olga V. Kotova ◽  
Elena S. Akarachkova ◽  
◽  
...  

Patients with musculoskeletal diseases (MSDs) constitute a heavy burden on the society. Therefore, there is a constant search for safe and efficient methods for treatment of such conditions, in which inflammation underlies the pathogenetic process. Chronic back pain is associated with physical inactivity and other lifestyle factors, such as tobacco consumption, poor dietary habits, overweight, poor sleep quality, and uncontrollable stress. For example, obesity is associated with low-grade chronic systemic inflammation, and is, therefore, a significant risk factor for occurrence and chronicity of back pain. The patient's lifestyle may contribute to MSDs, including chronic MSDs associated with inflammation and decreased functional capacity, both independently or in combination with other risk factors. The most common drugs used for treatment of MSDs are the non-steroidal anti-inflammatory drugs (NSAIDs). However, taking into account the possible NSAID-induced adverse events, the physicians are constantly thinking about ways to reduce the risks. В vitamins (B1, B6 and B12) possess analgesic and anti-inflammatory effects, which are discussed in the paper. When used in combination with NSAIDs, particularly in combination of diclofenac with vitamins B1, B6 and B12, the B vitamins possess some other positive effects contributing to restoration of mobility, pain relief and functional recovery in patients with low back pain. Such combination (diclofenac + vitamins B1, B6 and B12) is represented on the Russian market by Neurodiclovit, the successful use of which is discussed in the case report.

Spine ◽  
1997 ◽  
Vol 22 (17) ◽  
pp. 2030-2034 ◽  
Author(s):  
Alexander R. Vaccaro ◽  
David Ring ◽  
Gaetano Scuderi ◽  
Dan S. Cohen ◽  
Steven R. Garfin

2018 ◽  
Author(s):  
Mashfiqui Rabbi ◽  
Min SH Aung ◽  
Geri Gay ◽  
M Cary Reid ◽  
Tanzeem Choudhury

BACKGROUND Chronic pain is a globally prevalent condition. It is closely linked with psychological well-being, and it is often concomitant with anxiety, negative affect, and in some cases even depressive disorders. In the case of musculoskeletal chronic pain, frequent physical activity is beneficial. However, reluctance to engage in physical activity is common due to negative psychological associations (eg, fear) between movement and pain. It is known that encouragement, self-efficacy, and positive beliefs are effective to bolster physical activity. However, given that the majority of time is spent away from personnel who can give such encouragement, there is a great need for an automated ubiquitous solution. OBJECTIVE MyBehaviorCBP is a mobile phone app that uses machine learning on sensor-based and self-reported physical activity data to find routine behaviors and automatically generate physical activity recommendations that are similar to existing behaviors. Since the recommendations are based on routine behavior, they are likely to be perceived as familiar and therefore likely to be actualized even in the presence of negative beliefs. In this paper, we report the preliminary efficacy of MyBehaviorCBP based on a pilot trial on individuals with chronic back pain. METHODS A 5-week pilot study was conducted on people with chronic back pain (N=10). After a week long baseline period with no recommendations, participants received generic recommendations from an expert for 2 weeks, which served as the control condition. Then, in the next 2 weeks, MyBehaviorCBP recommendations were issued. An exit survey was conducted to compare acceptance toward the different forms of recommendations and map out future improvement opportunities. RESULTS In all, 90% (9/10) of participants felt positive about trying the MyBehaviorCBP recommendations, and no participant found the recommendations unhelpful. Several significant differences were observed in other outcome measures. Participants found MyBehaviorCBP recommendations easier to adopt compared to the control (βint=0.42, P<.001) on a 5-point Likert scale. The MyBehaviorCBP recommendations were actualized more (βint=0.46, P<.001) with an increase in approximately 5 minutes of further walking per day (βint=4.9 minutes, P=.02) compared to the control. For future improvement opportunities, participants wanted push notifications and adaptation for weather, pain level, or weekend/weekday. CONCLUSIONS In the pilot study, MyBehaviorCBP’s automated approach was found to have positive effects. Specifically, the recommendations were actualized more, and perceived to be easier to follow. To the best of our knowledge, this is the first time an automated approach has achieved preliminary success to promote physical activity in a chronic pain context. Further studies are needed to examine MyBehaviorCBP’s efficacy on a larger cohort and over a longer period of time.


2019 ◽  
Vol 49 (2) ◽  
pp. 275-279
Author(s):  
I. Z. Gaydukova ◽  
D. M. Bichurina ◽  
Yu. R. Popova ◽  
A. P. Rebrov

Neurosurgery ◽  
2020 ◽  
Vol 87 (2) ◽  
pp. 166-175 ◽  
Author(s):  
Teddy E Kim ◽  
Robert K Townsend ◽  
Charles L Branch ◽  
Edgar A Romero-Sandoval ◽  
Wesley Hsu

Abstract Marijuana is increasingly utilized for the treatment of multiple medical problems, including back pain, in the United States. Although there is strong preclinical evidence supporting the promise of cannabinoids in the treatment of back pain, there is a paucity of clinical data supporting their use in clinical practice. Opioids are an important medication for the treatment of acute and chronic back pain, but utilization of opioid-based regimens have likely contributed to the growing opioid epidemic. The significant risk of morbidity, mortality, and dependence secondary to opioid medications have increased the interest in nonopioid medications, including cannabinoid-based pain regimens, in treating back pain. This review will provide an overview on the pharmacology, drug delivery methods, clinical evidence, and safety considerations critical to understanding the potential role of cannabinoids in the treatment of back pain.


2004 ◽  
Vol 22 (4) ◽  
pp. 203-206 ◽  
Author(s):  
Hywel Watkin

Back pain is common, and although many cases remit quickly, a significant number also continue a relapsing course over many months and years. Psychosocial factors have a significant influence on the condition. The evidence from clinical trials of the effectiveness of various therapies is available in summarised form in several resources, though is often inconclusive. There is good evidence that acute back pain should be managed by staying active and using non-steroidal anti-inflammatory and analgesic drugs, adding cognitive behaviour therapy for subacute pain. For chronic back pain, exercise, pain management programmes, non-steroidal anti-inflammatory and analgesic drugs, and trigger point and ligament injections are also recommended. There appears to be increasing evidence in favour of the use of acupuncture. Acupuncture appears to be useful to treat back pain, but patients should probably be advised to take advantage of any pain relief obtained to maintain or increase their activity. Acupuncturists must be aware of the psychosocial dimensions of back pain, as well as the physical ones, and should be careful to educate their patients about the condition and not make them become dependent on acupuncture to treat every acute episode.


2019 ◽  
Vol 12 ◽  
pp. 175628481985803 ◽  
Author(s):  
Stefanos Tyrovolas ◽  
Demosthenes B. Panagiotakos ◽  
Ekavi N. Georgousopoulou ◽  
Christina Chrysohoou ◽  
John Skoumas ◽  
...  

Background: Nonalcoholic fatty liver disease (NAFLD) is correlated with low-grade inflammation and dietary habits. Until today, there have been limited epidemiologic data assessing the role of diet’s inflammatory potential on NAFLD. The aim was to evaluate the relationship between an anti-inflammatory diet, as reflected by the Dietary Anti-Inflammation Index (D-AII), and NAFLD among cardiovascular disease (CVD)-free adults. Methods: ATTICA is a prospective, population-based study that recruited 3042 adults without pre-existing CVD from the Greek population (Whites; age ⩾18 years; 1514 men and 1528 women). D-AII was calculated using a standard procedure. The baseline study captured various sociodemographic, lifestyle and clinical characteristics as well as hepatic markers. These were used to calculate four NAFLD assessment indices: triglyceride-glucose (TyG) index, fatty liver index (FLI), hepatic steatosis index (HSI), and NAFLD Fatty Liver Score (NAFLD-FLS). Specific cutoffs were applied to capture NAFLD. Results: D-AII showed a significant inverse association with NAFLD, applying the four indices with NAFLD cutoffs [odds ratio (OR) with 95% confidence interval (CI); TyG (0.95, 0.93–0.98); HSI (0.89, 0.86–0.92); FLI (0.88, 0.85–0.91); NAFLD-FLS (0.89, 0.86–0.92)], after adjusting for various confounders. Participants in the highest D-AII tertile had lower odds of having NAFLD, compared with those in the lowest D-AII tertile [(OR, 95% CI); TyG (0.33, 0.24–0.47); HSI (0.13, 0.08–0.23); FLI (0.05, 0.02–0.11); NAFLD-FLS (0.13, 0.07–0.23)]. Anti-inflammatory nutrition was related to lower odds of NAFLD among daily alcohol drinkers and individuals with metabolic syndrome. Conclusions: Anti-inflammatory diet is an important predictor of NAFLD among adults without pre-existing CVD. Adherence to a high anti-inflammatory diet seems to contribute to NAFLD prevention.


2020 ◽  
Author(s):  
James F. Markworth ◽  
Lemuel A. Brown ◽  
Eunice Lim ◽  
Jesus A. Castor-Macias ◽  
Jacqueline Larouche ◽  
...  

AbstractChronic inflammation and deregulated acute immune cell responses to injury contribute to age-associated skeletal muscle dysfunction. Specialized pro-resolving mediators (SPMs) control inflammation and support myofiber regeneration in young mice, but their role in aging muscle remains unknown. Here we examined the effect of age on the mediator lipidome of skeletal muscle via LC-MS based lipidomic profiling and tested whether systemic administration of the SPM resolvin D1 (RvD1) could limit excessive inflammation and improve the regenerative capacity of aged muscle. Aged mice displayed chronic low-grade muscle inflammation prior to injury and this was associated with a basal deficiency of lipoxygenase (LOX) derived SPMs as well as anti-inflammatory cytochrome P450 (CYP) derived lipid epoxides. Following muscle damage, young and aged mice produced similar amounts of pro-inflammatory cyclooxygenase (COX) and 12-LOX metabolites, but aged mice mounted a markedly deficient SPM response. This was associated with heightened leukocyte recruitment, impaired myofiber regeneration, and delayed recovery of strength. Systemic treatment with RvD1 had minimal impact on excessive myeloid cell infiltration and defective myofiber regeneration in aged mice. Nevertheless, RvD1 treatment did suppress inflammatory cytokines, modulated muscle stem cells, limited maladaptive tissue remodeling, and improved recovery of specific muscle force. We conclude that aging results in a marked deficiency of local SPM biosynthesis within muscle and that immunoresolvents may be attractive novel therapeutics for the treatment of muscular injuries and associated pain in the elderly, due to positive effects on recovery of muscle function without the negative side effects on myofiber regeneration of traditional anti-inflammatory treatments.


Author(s):  
Ю.А. Меркулов ◽  
А.Е. Гореликов ◽  
А.А. Пятков ◽  
Д.М. Меркулова

Цель обзора - анализ результатов исследований эффективности ритмической транскраниальной и трансспинальной магнитной стимуляции (рТМС и рТсМС) в лечении боли в пояснице. Хроническая боль в нижней части спины (ХБНЧС) преобладает над другими видами боли и, выходя за нозологические рамки болезней опорно-двигательного аппарата, поражает около 80-84% населения в течение жизни. Нейропластичность, лежащая в основе патогенеза ХБНЧС, управляется стимулами, которые могут быть опосредованы процессами, происходящими как «сверху вниз», от вышележащих к нижерасположенным иерархическим структурам нервной системы, так и «снизу вверх», - от периферических к центральным. Это находит отражение в повышенном интересе профессионального сообщества регенеративной медицины к применению высокотехнологических методов нейромодуляции ритмическими электромагнитными импульсами при ХБНЧС. Во второй части обзора представлен метаанализ накопленных к моменту его публикации литературных данных. Он дополняет опубликованную ранее информацию о том, что и рТМС, и рТсМС относятся к перспективным патогенетическим терапевтическим методам для пациентов с ХБНЧС, основываясь на экспериментальных и клинических эффектах положительного влияния на искаженную сенсорную передачу, изменение проприоцепции, управление движением и психологическую модуляцию. Обе методики зарекомендовали себя в кратковременном облегчении хронической дорсалгии, в то время как долгосрочные последствия рТсМС (>1 месяца) должны быть исследованы далее. Различные факторы, связанные с унификацией пока еще разнородных протоколов стимуляции, включая форму подачи импульсов, частоту, место приложения, регулярность и продолжительность лечения, могут улучшить дальнейшую надлежащую трактовку ее результатов. Очевидная по мнению авторов настоящего обзора, но до настоящего времени не описанная в литературе комбинация рТМС и рТсМС при ХБНЧС, могла бы повлиять на процессы управления болью при изучаемой патологии в большей степени, чем каждая из них по отдельности. The aim of this review was to analyze results of studies on the effectiveness of repetitive transcranial and transspinal magnetic stimulation (rTMS and rTsMS) in the treatment of low back pain. Chronic low back pain (CLBP) is prevalent over other types of pain and, beyond the nosological scope of musculoskeletal diseases, affects about 80-84% of the population in a lifetime. Neuroplasticity underlying the pathogenesis of CLBP is driven by stimuli, and stimuli can be mediated by processes from «top to bottom», i.e. from the overlying to the underlying hierarchical structures of the nervous system, and vice versa, i.e. from peripheral to the central. This is reflected in the increased interest of the professional community of regenerative medicine in implementing high-tech methods of neuromodulation by repetitive electromagnetic pulses in CLBP. In this second part of the review, we present a meta-analysis of the literature data accumulated by the time of its publication. It completes our previously published information stating that both rTMS and rTsMS are viable pathogenetic therapeutic modalities for patients with CLBP, based on experimental and clinical positive effects on impaired sensory transmission, changes in proprioception, motor control, and psychological modulation. Both methods have proven successful in providing short-term relief for chronic dorsalgia, while the long-term effects of rTsMS (>1 month) require further investigation. Various factors associated with the unification of the still heterogeneous stimulation protocols, including pulse delivery form, frequency, application location, periodicity and treatment duration, may further improve proper result interpretation. The combination of rTMS and rTsMS in CLBP, which is evident to the authors of this review but has not been described in the literature yet, could have more impact on the pain management processes of the investigated pathology than each of them separately.


2016 ◽  
Author(s):  
Jianguo Cheng

Diskogenic low back pain (LBP), defined as pain that originates from a damaged vertebral disk, is a common cause of LBP. It is characterized by a three-phase cascade of degeneration marked by dysfunction, instability, and stabilization. A distinct pathologic characteristic of the disks from patients with diskogenic LBP has been found to be the formation of the zones of vascularized granulation tissue, with extensive innervation extending from the outer layer of the annulus fibrosus into the nucleus pulposus along a torn fissure. In addition, there appears to be an association between microbial infection and symptomatic disk degeneration. Low-virulence microorganisms, in particular Propionibacterium acnes, might be causing a chronic low-grade infection in the lower intervertebral disks in some patients. The diagnosis of diskogenic pain is primarily based on clinical manifestations, physical examinations, imaging studies, and provocative diskography. Diskogenic pain should be differentiated from other axial back pain conditions, such as facet arthropathy, sacroiliac joint pain, myofascial strain and pain, vertebral compression fracture, and other, less common conditions. Treatment options should be tailored to individual needs. Early and gradual physical and behavioral therapies are encouraged. Pharmacologic therapy, composed primarily of analgesics, nonsteroidal antiinflammatory drugs, muscle relaxants, and antidepressants, may have modest positive effects. A subset of patients with Modic type I changes in magnetic resonance imaging may benefit antibiotic therapy directed at the infected disks by P. acnes and other low-virulence microorganisms. There is evidence that supports the use of epidural steroid injections and intradiskal injections (methylene blue, ozone, steroids) for diskogenic pain. Additional options include intradiskal biacuplasty, gray ramus communicans nerve blocks/radiofrequency ablation, and intradiskal stem cell injections for disk repair/regeneration, all of which have gained support in clinical trials. These treatment modalities have shown promise to provide equal or even better outcomes compared with surgical spinal fusion or total disk replacement with an artificial disk.    This review contains 2 figures and 149 references. Keywords: collagen, diskogenic low back pain (LBP), herniation, intervertebral disk, spondylosis


Author(s):  
Annalisa Rizzo ◽  
Raffaele Luigi Sciorsci ◽  
Thea Magrone ◽  
Emilio Jirillo

Background and Objectives: Dietary habits strongly influence our health status, mostly, in terms of maintenance of the inflammatory/anti-inflammatory homeostasis. High fat and high sugar diets account for the development of a low-grade inflammation which is the pathogenic common denominator of various chronic disease. Severe Acute Respiratory Syndrome Coronavirus (SARS)-CoV2 (COVID-19) infection affects all ages and especially frail elderly people and a nutri-tional intervention seems to be crucial in the course of this pandemic. The present review describes the properties of some vegetal products and their derivatives, such as Lupin sp., garlic, salvia and extra virgin olive oil (EVOO) that can be exploit-ed for their beneficial effects, as preventive and/or nutritional treatment of coronavirus disease SARS-CoV2. Discussion: Lupin, salvia, garlic and EVOO share overlapping properties, such as anti-oxidant, anti-inflammatory and anti-viral activities. Quite importantly, these products and their derivatives are able to recover the expression of angiotensin con-verting enzyme expression 2 on cell membrane, otherwise suppressed by COVID-19 binding and entry into cytoplasm. Conclusion: Dietary administration of the above nutraceuticals or their extracts may play a preventive or nutritional role in the course of SARS-CoV2 infection, even including the effects of the lockdown and the condition of inflamm-ageing.


Sign in / Sign up

Export Citation Format

Share Document